A detailed history of Inceptionr LLC transactions in Biogen Inc. stock. As of the latest transaction made, Inceptionr LLC holds 6,694 shares of BIIB stock, worth $1.06 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
6,694
Previous 3,552 88.46%
Holding current value
$1.06 Million
Previous $823 Million 57.58%
% of portfolio
0.32%
Previous 0.23%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$189.07 - $236.8 $594,057 - $744,025
3,142 Added 88.46%
6,694 $1.3 Billion
Q2 2024

Aug 13, 2024

SELL
$190.52 - $236.72 $503,734 - $625,887
-2,644 Reduced 42.67%
3,552 $823 Million
Q1 2024

May 09, 2024

BUY
$212.02 - $267.71 $790,198 - $997,755
3,727 Added 150.95%
6,196 $1.34 Billion
Q4 2023

Feb 08, 2024

SELL
$222.59 - $267.94 $199,885 - $240,610
-898 Reduced 26.67%
2,469 $639 Million
Q3 2023

Nov 14, 2023

BUY
$253.3 - $285.89 $852,861 - $962,591
3,367 New
3,367 $865 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.8B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Inceptionr LLC Portfolio

Follow Inceptionr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inceptionr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inceptionr LLC with notifications on news.